Close Menu

ACMG

Returning incidental findings from exome sequencing tests likely won't bankrupt the health system and may increase quality of life at a reasonable cost.

The American College of Medical Genetics & Genomics updated its recommendations for the analysis & reporting of secondary findings from clinical genome-scale sequencing & released results of a 2013 about its initial recommendations from 2013.

Originally published Sept. 15.
NEW YORK (GenomeWeb) – Numerous studies by now have come to the conclusion that primary care physicians' lack of genomics knowhow is hindering their adoption of molecularly guided treatment strategies.

NEW YORK (GenomeWeb) – A survey of genetics professionals conducted by researchers from the University of Washington has found that, on the whole, respondents' views on when and how to return incidental findings from whole genome and exome sequencing differed substantially from professional recom

SAN DIEGO (GenomeWeb News) — Reporting incidental or secondary findings may pose a challenge for the cancer field, a panel at this year's American Association for Cancer Research meeting said.

NEW YORK (GenomeWeb News) – The American College of Medical Genetics and Genomics is updating its recommendations on the return of incidental findings results to individuals who have had their genomes or exomes sequenced in the clinical setting.

David Flannery, a pediatric geneticist, is the new medical director of the American College of Medical Genetics and Genomics.

Pages

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.